Mpex Pharmaceuticals - Specializing in New Antibiotics for Serious Infections and Bacterial Resistance
    Home Research Team News Employment Contact
Management
Board of Directors
Science Advisory Board

 


Team

Scott R. Pancoast
President and CEO, Lpath Therapeutics

Prior to his current position with Lpath Therapeutics, Mr. Pancoast served for ten years as the Managing Director of Western States Investment Group, a privately owned venture capital investment firm, with over $100 million of assets under management. Mr. Pancoast has served on over fifteen boards over the last decade and is currently serving on six.  Prior to joining Western States, Mr. Pancoast was Senior Vice President and a Board Member of a $300 million publicly-traded firm, where he founded, managed, and rapidly grew the company's Midwest Division. Mr. Pancoast holds a B.A. in economics from the University of Virginia (summa cum laude) and an MBA from the Harvard Business School.